癌症相关失眠评估工具及其评价指标研究进展

Patient-reported Outcomes and Assessment Methods of Cancer-related Insomnia

失眠是困扰癌症患者的一个突出问题,不仅影响癌症患者生命质量,还会增加疾病进展风险。患者报告结局可以有效评价失眠及其伴随症状负担,而对失眠的准确评估,能帮助患者进行有效的症状控制和改善生命质量。本文梳理了已经在癌症患者群体中验证过的主观评估量表[匹兹堡睡眠质量指数(PSQI)、失眠严重程度指数(ISI)、阿森斯失眠量表(AIS)]和客观评估工具[多导睡眠仪检测(PSG)、多睡眠潜伏期测试(MSLT)、腕动仪(Actigraphy)、双谱指数(BIS)],以期帮助临床和科研工作者合理应用评估工具,更好地改善癌症患者失眠症状,开展临床研究。

Insomnia is a prominent problem that plagues cancer patients.It not only impair the quality of life,but also increases the risk of disease progression.Effective treatments for symptom control and improving quality of life are based on accurate assessment of insomnia.The outcome reported by the patient can evaluate insomnia,and it accompanies symptom burden and quality of life.This paper sorts out the subjective assessment scales that have been validated in cancer patients[Pittsburgh Sleep Quality Index(PSQI),Insomnia Severity Index(ISI),Athens Insomnia Scale(AIS)]and objective assessment tools[polysomnography Test(PSG),Multiple Sleep Latency Test(MSLT),Actigraphy,Bispectral Index(BIS)].In order to help clinical working groups and researchers rationally use assessment tools,better manage the insomnia symptoms of cancer patients,and carry out clinical research,clinical researches are conducted.